Seattle-based University of Washington Medicine and Next Steps Chicago were among the first commercial U.S. sales. Arc-EX earned de novo classification in December and is the first FDA-approved technology that is indicated to improve hand strength in people with spinal cord injuries.
Onward Medical is seeking a CE mark from the European Union for Arc-EX in 2025 along with a commercial launch abroad.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
